tiprankstipranks
Trending News
More News >
Taysha Gene Therapies, Inc. (TSHA)
:TSHA
US Market

Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?

Compare
1,229 Followers

Taysha Gene Therapies (TSHA) Ownership Overview

12.37%9.37%49.37%10.44%18.46%
12.37% Insiders
49.37% Other Institutional Investors
10.44% ETFs
18.46% Public Companies and Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 69.18% of the company’s stock is owned by Institutional Investors, 12.37% is owned by Insiders, and 18.46% is owned by Public Companies and Individual Investors.
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 58.74% of the company’s stock is owned by Institutional Investors, 12.37% is owned by Insiders, and 10.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 01, 2025
xxxxxxxxxxxxx
$1695906
Aug 22, 2025
xxxxxxxxxxxxx
$162604
Aug 22, 2025
xxxxxxxxxxxxx
$155299
Jun 03, 2025
xxxxxxxxxxxxx
$2062500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$11445
Sep 30, 2025
xxxxxxxxxxxxx
$1635000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,601,110Insider9.35%148,230,427
23,555,648Institution8.60%136,387,202
11,053,896Institution4.04%64,002,058
10,212,962Institution3.73%59,133,050
9,009,515Institution3.29%52,165,092
6,691,822Institution2.44%38,745,649
5,386,000Institution1.97%31,184,940
4,211,386Institution1.54%24,383,925
4,004,756Institution1.46%23,187,537
3,613,903Insider1.32%20,924,498

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,009,515Institution3.29%52,165,092
6,691,822Institution2.44%38,745,649
3,111,976Institution1.14%18,018,341
1,848,252Institution0.67%10,701,379
1,535,067Institution0.56%8,888,038
936,390Institution0.34%5,421,698
513,393Institution0.19%2,972,545
491,702Institution0.18%2,846,955
442,311Institution0.16%2,560,981
211,690Institution0.08%1,225,685

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,612,150Institution2.41%32,796,264
5,321,130Institution1.94%30,649,709
3,634,820Institution1.33%20,936,563
2,348,937Institution0.86%11,650,728
1,888,038Institution0.69%10,875,099
1,639,889Institution0.60%9,445,761
1,058,221Institution0.39%6,095,353
1,026,196Institution0.37%5,089,932
572,547Institution0.21%3,297,871
514,298Institution0.19%2,550,918

FAQ

Who Owns Taysha Gene Therapies, Inc. (TSHA)?
According to the latest TipRanks data, approximately 49.37% of the company's stock is held by institutional investors, 12.37% is held by insiders, and 18.46% is held by retail investors.
    What percentage of Taysha Gene Therapies, Inc. (TSHA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.37% of Taysha Gene Therapies, Inc. (TSHA) stock is held by institutional investors.
      What percentage of Taysha Gene Therapies, Inc. (TSHA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 18.46% of Taysha Gene Therapies, Inc. (TSHA) stock is held by retail investors.
        Who owns the most shares of Taysha Gene Therapies, Inc. (TSHA)?
        Paul B Manning owns the most shares of Taysha Gene Therapies, Inc. (TSHA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.